Celgene (CELG) Misses Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. S
10. COF

Go back to Celgene (CELG) Misses Q4 EPS by 4c

Celgene Reports Fourth Quarter and Full Year 2015 Operating and Financial Results

January 28, 2016 7:30 AM EST

Data from at Least 18 Phase III Trials Expected from Mid-2016 Through Mid-2018 2016 Guidance for Total Net Product Sales, REVLIMID® Net Sales and Diluted EPS

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) reported operating results for the fourth quarter and full year of 2015. For the fourth quarter of 2015, net product sales were $2,539 million compared to $2,055 million from the same period in 2014, an increase of 24 percent. The net negative impact of currency on net product sales was 1 percent.... More